Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CHEMBIO DIAGNOSTICS, INC.

(CEMI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Gain Premarket Friday

08/27/2021 | 09:16am EST


© MT Newswires 2021
All news about CHEMBIO DIAGNOSTICS, INC.
11/22CHEMBIO DIAGNOSTICS : Diagnostic Systems Prevails in International Arbitration Against Bio..
PU
11/22CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/22Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) L..
AQ
11/16Chembio Submits EUA for Rapid Covid-19 Antigen Test
DJ
11/16Chembio Diagnostics Seeks US FDA Emergency Use Authorization for New COVID-19 Antigen T..
MT
11/16Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
GL
11/16Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
CI
11/15CHEMBIO DIAGNOSTICS, INC. : Change in Directors or Principal Officers, Other Events (form ..
AQ
11/15Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchas..
AQ
11/15Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchas..
CI
More news
Analyst Recommendations on CHEMBIO DIAGNOSTICS, INC.
More recommendations
Financials (USD)
Sales 2021 40,8 M - -
Net income 2021 -25,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,91x
Yield 2021 -
Capitalization 60,1 M 60,1 M -
Capi. / Sales 2021 1,47x
Capi. / Sales 2022 1,53x
Nbr of Employees 355
Free-Float 94,2%
Chart CHEMBIO DIAGNOSTICS, INC.
Duration : Period :
Chembio Diagnostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHEMBIO DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 2,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Richard L. Eberly President, Chief Executive Officer, CFO & Director
Katherine Lyon Davis Chairman
Javan Esfandiari Chief Science & Technology Officer
Paul Lambotte Vice President-Research & Development
Paul J. Angelico Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
CHEMBIO DIAGNOSTICS, INC.-57.89%60
JOHNSON & JOHNSON1.82%421 847
ROCHE HOLDING AG17.17%334 769
PFIZER, INC.46.70%285 639
NOVO NORDISK A/S68.76%247 704
ELI LILLY AND COMPANY54.21%237 527